These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25085901)

  • 1. A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance.
    Xu X; Wells A; Padilla MT; Kato K; Kim KC; Lin Y
    Carcinogenesis; 2014 Nov; 35(11):2457-66. PubMed ID: 25085901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-interacting protein 1 increases chemoresistance by maintaining inhibitor of apoptosis protein levels and reducing reactive oxygen species through a microRNA-146a-mediated catalase pathway.
    Wang Q; Chen W; Bai L; Chen W; Padilla MT; Lin AS; Shi S; Wang X; Lin Y
    J Biol Chem; 2014 Feb; 289(9):5654-63. PubMed ID: 24425875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells.
    Kharbanda A; Rajabi H; Jin C; Alam M; Wong KK; Kufe D
    Oncotarget; 2014 Oct; 5(19):8893-905. PubMed ID: 25245423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the MUC1-C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma.
    Shigeta K; Hasegawa M; Kikuchi E; Yasumizu Y; Kosaka T; Mizuno R; Mikami S; Miyajima A; Kufe D; Oya M
    Cancer Sci; 2020 Oct; 111(10):3639-3652. PubMed ID: 32677159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner.
    Jin W; Liao X; Lv Y; Pang Z; Wang Y; Li Q; Liao Y; Ye Q; Chen G; Zhao K; Huang L
    Cell Death Dis; 2017 Aug; 8(8):e2980. PubMed ID: 28796259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
    Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
    Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells.
    Li Z; Xu X; Bai L; Chen W; Lin Y
    J Biol Chem; 2011 Jun; 286(24):21164-72. PubMed ID: 21525012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells.
    Raina D; Uchida Y; Kharbanda A; Rajabi H; Panchamoorthy G; Jin C; Kharbanda S; Scaltriti M; Baselga J; Kufe D
    Oncogene; 2014 Jun; 33(26):3422-31. PubMed ID: 23912457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC1 regulates AKT signaling pathway by upregulating EGFR expression in ovarian cancer cells.
    Ma Q; Song J; Wang S; He N
    Pathol Res Pract; 2021 Aug; 224():153509. PubMed ID: 34118726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of microRNA-136 induces apoptosis and radiosensitivity of esophageal squamous cell carcinoma cells by inhibiting the expression of MUC1.
    Huang HZ; Yin YF; Wan WJ; Xia D; Wang R; Shen XM
    Exp Mol Pathol; 2019 Oct; 110():104278. PubMed ID: 31247211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism.
    Olou AA; King RJ; Yu F; Singh PK
    Oncogene; 2020 Apr; 39(16):3381-3395. PubMed ID: 32103170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.
    Tréhoux S; Lahdaoui F; Delpu Y; Renaud F; Leteurtre E; Torrisani J; Jonckheere N; Van Seuningen I
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2392-403. PubMed ID: 26036346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the oncogenic MUC1-C protein inhibits mutant EGFR-mediated signaling and survival in non-small cell lung cancer cells.
    Kharbanda A; Rajabi H; Jin C; Tchaicha J; Kikuchi E; Wong KK; Kufe D
    Clin Cancer Res; 2014 Nov; 20(21):5423-34. PubMed ID: 25189483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of miR-143 overexpression on proliferation, apoptosis, EGFR and downstream signaling pathways in PC9/GR cell line.
    Dong YZ; Hu T
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1709-1716. PubMed ID: 29630116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
    Wu H; Xiao Z; Wang K; Liu W; Hao Q
    Biochem Biophys Res Commun; 2013 Nov; 441(4):693-700. PubMed ID: 24157791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer.
    Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D
    Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells.
    Rajabi H; Joshi MD; Jin C; Ahmad R; Kufe D
    Prostate; 2011 Sep; 71(12):1299-308. PubMed ID: 21308711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Glycosylated
    Miyazaki K; Kishimoto H; Kobayashi H; Suzuki A; Higuchi K; Shirasaka Y; Inoue K
    Mol Pharmacol; 2023 Mar; 103(3):166-175. PubMed ID: 36804202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway.
    Xu F; Gu J; Lu C; Mao W; Wang L; Zhu Q; Liu Z; Chu Y; Liu R; Ge D
    Int J Biol Sci; 2019; 15(1):127-137. PubMed ID: 30662353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines.
    Wang YS; Wang YH; Xia HP; Zhou SW; Schmid-Bindert G; Zhou CC
    Asian Pac J Cancer Prev; 2012; 13(1):255-60. PubMed ID: 22502680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.